GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akouos Inc (NAS:AKUS) » Definitions » FCF Margin %

Akouos (Akouos) FCF Margin % : 0.00% (As of Sep. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Akouos FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Akouos's Free Cash Flow for the three months ended in Sep. 2022 was $-23.70 Mil. Akouos's Revenue for the three months ended in Sep. 2022 was $0.00 Mil. Therefore, Akouos's FCF Margin % for the quarter that ended in Sep. 2022 was 0.00%.

As of today, Akouos's current FCF Yield % is -18.39%.

The historical rank and industry rank for Akouos's FCF Margin % or its related term are showing as below:


AKUS's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -147.18
* Ranked among companies with meaningful FCF Margin % only.


Akouos FCF Margin % Historical Data

The historical data trend for Akouos's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akouos FCF Margin % Chart

Akouos Annual Data
Trend Dec18 Dec19 Dec20 Dec21
FCF Margin %
- - - -

Akouos Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Akouos's FCF Margin %

For the Biotechnology subindustry, Akouos's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akouos's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Akouos's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Akouos's FCF Margin % falls into.



Akouos FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Akouos's FCF Margin for the fiscal year that ended in Dec. 2021 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-72.752/0
= %

Akouos's FCF Margin for the quarter that ended in Sep. 2022 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=-23.703/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akouos FCF Margin % Related Terms

Thank you for viewing the detailed overview of Akouos's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Akouos (Akouos) Business Description

Traded in Other Exchanges
N/A
Address
645 Summer Street, Suite 200, Boston, MA, USA, 02210
Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. The company is involved in developing potential genetic medicines for a variety of inner ear disorders.
Executives
Kearny Acquisition Corp 10 percent owner LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Lilly Eli & Co 10 percent owner LILLY CORPORATE CENTER, DROP CODE 1094, INDIANAPOLIS IN 46285
Jennifer Anne Wellman officer: Chief Operating Officer C/O AKOUOS, INC., 645 SUMMER STREET, SUITE 200, BOSTON MA 02210
Sachiyo Minegishi officer: Chief Financial Officer C/O AKOUOS, INC., 645 SUMMER STREET, SUITE 200, BOSTON MA 02210
5am Ventures V, L.p. 10 percent owner 2200 SAND HILL ROAD, SUITE 110, MENLO PARK CA 94025
Kush Parmar director, 10 percent owner C/O 5AM VENTURES, 501 2ND STREET, SUITE 350, SAN FRANCISCO CA 94107
Carmen Chang 10 percent owner 2855 SAND HILL ROAD, MENLO PARK CA 94025
Maha Katabi 10 percent owner SOFINNOVA INVESTMENTS, 3000 SAND HILL ROAD, 4-250, MENLO PARK CA 94025
Sofinnova Venture Partners X, L.p. 10 percent owner 3000 SAND HILL ROAD, 4-250, MENLO PARK CA 94025
Pivotal Bioventure Partners Fund I G.p., L.p. 10 percent owner 501 SECOND STREET, SUITE 200, SAN FRANCISCO CA 94107
New Enterprise Associates 16, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Paul Edward Walker 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Ecor1 Capital, Llc 10 percent owner 357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Cormorant Asset Management, Lp 10 percent owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Heather Preston director, 10 percent owner C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, FORT WORTH TX 76102

Akouos (Akouos) Headlines

From GuruFocus

FEDERATED HERMES, INC. Buys 2, Sells 3 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 09-16-2022